NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism - Takeaways - MDSpire

NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism

  • By

  • Yuting Cen

  • Li Li

  • Xinyu Ding

  • Chenyang Wang

  • Hua Qiu

  • July 10, 2026

  • 0 min

Share

  • 1

    NLRP12 functions as a context-dependent modulator in cancer, acting as either a tumor suppressor or promoter based on tumor type and environment.

  • 2

    In inflammation-associated cancers, NLRP12 suppresses tumor progression by inhibiting noncanonical NF-κB, Wnt/β-catenin, and JNK signaling.

  • 3

    In certain malignancies like gastric and ovarian cancer, NLRP12 is linked to tumor promotion through metabolic reprogramming and immune suppression.

  • 4

    NLRP12 connects inflammatory signaling with oncogenic pathways, metabolism, and immune responses, influencing tumor biology.

  • 5

    NLRP12 is emerging as a potential biomarker and therapeutic target in cancer, highlighting its dual roles in tumor ecosystems.

Original Source(s)

NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism

  • by Yuting Cen, Li Li, Xinyu Ding, Chenyang Wang, Hua Qiu

  • July 10, 2026

Related Content

Case Report: Thoracic SMARCA4-deficient undifferentiated tumor with extraocular muscle metastasis: a rare case hidden in diplopia

Eight-year disease-free survival in clear cell adenocarcinoma of the urethra with surgery alone: a case report and literature review

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

  • July 9, 2026

  • 12 min